Doug Scherrer
Co-Managing Member @ LASP Capital
Santa Monica, United States
Doug Scherrer is a seed investor at LASP Capital in Santa Monica focused on FinTech and Software. Doug Scherrer is the Co-Managing Member of LASP Capital. He previously worked at Efficient Alpha Capital LLC as a Founder and Managing Member. Doug Scherrer attended Princeton University
- Total investments:
- 15
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Doug Scherrer invests in
Stages Doug Scherrer invests in
Countries Doug Scherrer invests in
Investment Focus
Industry
- FinTech 3 (20%)
- Software 3 (20%)
- Information Technology 3 (20%)
- Artificial Intelligence 3 (20%)
- Medical 2 (13%)
Stage
- Seed 7 (47%)
- Series A 5 (33%)
- Angel 1 (7%)
- Pre-Seed 1 (7%)
- Series B 1 (7%)
Country
- Brazil 11 (73%)
- Switzerland 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Solomon
|
Solomon platform helps ecommerce brands optimize marketing campaigns with real-time dashboards. | $468.8K / Angel / Nov 20, 2025 | |
Neofin
|
AI-powered software for B2B payments workflows that automates and streamlines financial processes, transforming the way companies get paid and pay their bills | $6M / Seed / Feb 05, 2025 | |
Pilar
|
Pilar is a real estate brokerage service that provides efficiency in connecting clients and properties. | $6.5M / Series A / Jan 01, 2025 | |
|
Caliza
|
Provides an API that allows fintechs around the world to open digital dollar accounts for their users to save and transact. | $8.5M / Seed / Jul 15, 2024 | |
BeConfident
|
Practice English with AI on WhatsApp and video-calling | $500K / Pre-Seed / Apr 23, 2024 | |
|
BeConfident
|
Practice English with AI on WhatsApp and video-calling | $500K / Seed / Apr 23, 2024 | |
TissueLabs
|
TissueLabs is the platform for creating organs and tissues in the lab. We offer biomaterials, equipment, and services to support tissue engineering and regenerative medicine. Our products are created to allow performing state-of-the-art research, from drug discovery to organ fabrication. Currently, we are focused on attending the academic lifesciences market. In the future, our mission is to fabricate lab-grown tissues and organs, for both research and therapeutic applications. | $800K / Seed / Oct 01, 2023 | |
Comp
|
Strategy in every penny invested in your people.Comp is an agile partner that combines compensation and technology experts to align your Total Rewards strategy with business needs.From labor cost strategy to process automation, we are helping hundreds of innovative companies with job and salary management, short- and long-term incentives, meritcycles, people budgeting and more. | Seed / Sep 04, 2023 | |
Genial Care
|
Genial Care is an education and support space for those who care for children with autism. | $10M / Series A / Jan 01, 2023 | |
Mar Saúde
|
Mar Saúde utilizes the latest scientific evidence to detect diseases before symptoms appear allowing for early treatment. | Seed / Jan 01, 2023 | |
| See all 15 investments → | |||
Co-Investors
About LASP Capital
LASP Capital is a investment firm focuses on global growth companies.
LASP Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Doug Scherrer
Co-Managing Member
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Doug Scherrer invest in?
Doug Scherrer invests primarily in FinTech, Software and Information Technology startups, most often at Seed and Series A stage. Most of the 15 investments tracked by Shizune back companies in Brazil. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Doug Scherrer last invest?
The most recent investment recorded for Doug Scherrer closed in Nov 2025. Shizune tracks 15 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
